By: Karina Gonzalez
CMS recently published a white paper entitled “Healthcare Payer Strategies to Reduce the Harms of Opioids.” The white paper was prepared by the Healthcare Fraud Prevention Partnership (“HFPP”), which is a voluntary public-private partnership between the federal government, state agencies, law enforcement, private health insurers, employer organizations and fraud units to reduce fraud, waste and abuse. The white paper gives information and provides insight on the way payors view addiction treatment.
HFPP identified five actions that should be considered for implementation by all payors as quickly as possible.
- Train providers on Centers for Disease Control and Prevention guidelines for prescribing opioids for chronic pain;
- Promote access to and usage of Medication Assisted Treatment (MAT);
- Promote the availability of Naloxone;
- Encourage use of cross-payor data to identify fraudulent, wasteful or abusive practices associated with opioids in order to target corrective actions; and
- Identify and disseminate effective practices across the healthcare sector.